These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 38125886)
21. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies. Shende PK; Gaud RS; Bakal R; Patil D Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091 [TBL] [Abstract][Full Text] [Related]
22. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges. Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431 [TBL] [Abstract][Full Text] [Related]
23. Nanosponges for Drug Delivery and Cancer Therapy: Recent Advances. Iravani S; Varma RS Nanomaterials (Basel); 2022 Jul; 12(14):. PubMed ID: 35889665 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin. Mashaqbeh H; Obaidat R; Al-Shar'i NA AAPS PharmSciTech; 2022 Aug; 23(7):229. PubMed ID: 35974237 [TBL] [Abstract][Full Text] [Related]
25. Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: Formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation. Kumar S; Prasad M; Rao R Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111605. PubMed ID: 33321649 [TBL] [Abstract][Full Text] [Related]
26. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity. Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015 [TBL] [Abstract][Full Text] [Related]
27. Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host-Guest Complexes in a Comparative Evaluation. Peimanfard S; Zarrabi A; Trotta F; Matencio A; Cecone C; Caldera F Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631645 [TBL] [Abstract][Full Text] [Related]
28. Investigation of a new horizon antifungal activity with enhancing the antimicrobial efficacy of ciprofloxacin and its binary mixture via their encapsulation in nanoassemblies: in vitro and in vivo evaluation. Abou Taleb S; Darwish AB; Abood A; Mohamed AM Drug Dev Res; 2020 May; 81(3):374-388. PubMed ID: 31886590 [TBL] [Abstract][Full Text] [Related]
29. Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies. Aldawsari MF; Alhowail AH; Anwer MK; Ahmed MM Int J Nanomedicine; 2023; 18():2239-2251. PubMed ID: 37139486 [TBL] [Abstract][Full Text] [Related]
30. Cyclodextrin-based nanosponges as drug carriers. Trotta F; Zanetti M; Cavalli R Beilstein J Org Chem; 2012; 8():2091-9. PubMed ID: 23243470 [TBL] [Abstract][Full Text] [Related]
31. Incorporation of exemestane into ternary nanosponge system for enhanced anti-tumor potential in breast cancer. Mane PT; Wakure BS; Wakte PS Pharm Dev Technol; 2023 Dec; 28(10):1000-1015. PubMed ID: 37961995 [TBL] [Abstract][Full Text] [Related]
32. Nanosponge Carriers- An Archetype Swing in Cancer Therapy: A Comprehensive Review. Osmani RA; Hani U; Bhosale RR; Kulkarni PK; Shanmuganathan S Curr Drug Targets; 2017; 18(1):108-118. PubMed ID: 26424399 [TBL] [Abstract][Full Text] [Related]
33. Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments. Almutairy BK; Alshetaili A; Alali AS; Ahmed MM; Anwer MK; Aboudzadeh MA Polymers (Basel); 2021 Jul; 13(14):. PubMed ID: 34301030 [TBL] [Abstract][Full Text] [Related]
34. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid. Mady FM; Ibrahim SR Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214 [TBL] [Abstract][Full Text] [Related]
35. Cyclodextrin based nanosponges for pharmaceutical use: a review. Tejashri G; Amrita B; Darshana J Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895 [TBL] [Abstract][Full Text] [Related]
36. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia. Shende P; Deshmukh K; Trotta F; Caldera F Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237 [TBL] [Abstract][Full Text] [Related]
37. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine. Rao MRP; Chaudhari J; Trotta F; Caldera F AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305 [TBL] [Abstract][Full Text] [Related]
38. CDI cross-linked β-cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization. Sherje AP; Surve A; Shende P J Mater Sci Mater Med; 2019 Jun; 30(6):74. PubMed ID: 31197491 [TBL] [Abstract][Full Text] [Related]
39. Nanodispersions stabilized by β-cyclodextrin nanosponges: application for simultaneous enhancement of bioactivity and stability of sage essential oil. Nait Bachir Y; Nait Bachir R; Hadj-Ziane-Zafour A Drug Dev Ind Pharm; 2019 Feb; 45(2):333-347. PubMed ID: 30388376 [TBL] [Abstract][Full Text] [Related]
40. Formulation, Characterization, Anti-Inflammatory and Cytotoxicity Study of Sesamol-Laden Nanosponges. Nair AB; Dalal P; Kadian V; Kumar S; Kapoor A; Garg M; Rao R; Aldhubiab B; Sreeharsha N; Almuqbil RM; Attimarad M; Elsewedy HS; Shinu P Nanomaterials (Basel); 2022 Nov; 12(23):. PubMed ID: 36500833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]